Chan, Pui Ying
Alexander, Diana https://orcid.org/0000-0002-7785-3170
Mehta, Ishan https://orcid.org/0000-0002-2939-917X
Matsuyama, Larissa Satiko Alcantara Sekimoto https://orcid.org/0000-0002-5610-0030
Harle, Victoria
Olvera-León, Rebeca
Park, Jun Sung https://orcid.org/0000-0001-7149-6769
Arriaga-González, Fernanda G.
van der Weyden, Louise https://orcid.org/0000-0002-0645-1879
Cheema, Saamin https://orcid.org/0000-0002-5297-2042
Iyer, Vivek
Offord, Victoria
Barneda, David
Hawkins, Phillip T. https://orcid.org/0000-0002-6979-0464
Stephens, Len
Kozik, Zuza
Woods, Michael
Wong, Kim
Balmus, Gabriel https://orcid.org/0000-0003-2872-4468
Vinceti, Alessandro
Thompson, Nicola A.
Del Castillo Velasco-Herrera, Martin https://orcid.org/0000-0001-5956-0211
Wessels, Lodewyk https://orcid.org/0000-0002-1656-6995
van de Haar, Joris
Gonçalves, Emanuel https://orcid.org/0000-0002-9967-5205
Sinha, Sanju
Vázquez-Cruz, Martha Estefania
Bisceglia, Luisa
Raimondi, Francesco https://orcid.org/0000-0002-6891-3178
Choudhary, Jyoti https://orcid.org/0000-0003-0881-5477
Patiyal, Sumeet
Venkatesh, Anjan
Iorio, Francesco https://orcid.org/0000-0001-7063-8913
Ryan, Colm J. https://orcid.org/0000-0003-2750-9854
Adams, David J. https://orcid.org/0000-0001-9490-0306
Funding for this research was provided by:
Wellcome Trust (220540/Z/20/A, 220540/Z/20/A, 220540/Z/20/A, 220540/Z/20/A, 220540/Z/20/A, 220540/Z/20/A, 220540/Z/20/A, 220540/Z/20/A, 220540/Z/20/A, 220540/Z/20/A, 220540/Z/20/A, 220540/Z/20/A, 220540/Z/20/A, 220540/Z/20/A, 220540/Z/20/A, 220540/Z/20/A, 220540/Z/20/A, 220540/Z/20/A, 220540/Z/20/A)
RCUK | Biotechnology and Biological Sciences Research Council (1, 1, 1)
Center for Strategic Scientific Initiatives, National Cancer Institute (1, 1)
Article History
Received: 28 November 2023
Accepted: 9 May 2025
First Online: 4 July 2025
Competing interests
: D.J.A. has received precompetitive funding from AstraZeneca and OpenTargets. F.I. provides consultancy services for the joint Cancer Research Horizons–AstraZeneca Functional Genomics Centre and for Mosaic Therapeutics. F.I. also receives funding from OpenTargets and Nerviano Medical Sciences Srl. The remaining authors declare no competing interests.